RARE DISEASERESEARCH ATLAS
Open navigation menu

ORPHA:251383

CK syndrome

low confidenceDisorder

Also known as: X-linked intellectual disability-microcephaly-cortical malformation-thin habitus syndrome

Publications

2,025

Trials

0

Interventional, condition-specific

Researchers

326

Distinct authors in sample

Gene link

NSDHL

Definitive

Readiness

3/6

Stages with a signal

Clinical definition (Orphanet)

CK syndrome is a rare, genetic, X-linked syndromic disorder characterized by mild to severe , infancy-onset , post-natal microcephaly, cerebral cortical malformations, facial features (including long, narrow face, almond-shaped palpebral fissures, epicanthic folds, high nasal bridge, malar flattening, posteriorly rotated ears, high arched palate, crowded teeth, micrognathia) and thin body habitus. Long and slim fingers/toes, strabismus, , spasticity, optic disc atrophy, and behavioral problems (aggression, attention deficit hyperactivity disorder and irritability) are additional features.

How rare: <1 / 1 000 000 — fewer than one in a million. In a city the size of Kolkata, that might mean on the order of fifteen people.

Orphanet entry

Cross-references

Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.

Additional Mondo synonyms (1)

CK syndrome, X-linked recessive

Research stages

Trial readiness signals

Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”

3/6 stages with a signal

No matched interventional trial; the gene is known and literature exists — preclinical or natural-history work may still be the practical next step.

  1. Gene identifiedPresent

    Definitive — NSDHL

  2. LiteraturePresent

    2,025 matched papers (1,353 in last 10 years) Source

  3. Phenotype characterisedPresent

    67 HPO annotations (e.g. Strabismus; High palate; Hyperactivity) Source

  4. Animal modelNot found

    No Alliance genotype “model of” associations via Monarch for these Mondo IDs

  5. Orphan designationNot found

    No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source

  6. Interventional trialNot found

    No matched interventional trial under our ClinicalTrials.gov rules

Biology

Genes and phenotypes

Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.

Do we know what causes it?

Yes — we know a specific gene responsible (NSDHL).

GenCC classification: Definitive.

Phenotypes (Monarch / HPO)

67

Associated phenotypes · MONDO:0010441

  • Strabismus
  • High palate
  • Hyperactivity
  • Pachygyria
  • Retrognathia

Showing 5 of 67 — open Monarch for the full list.

Animal models (Monarch / Alliance)

None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.

Monarch fetch 2026-07-29

Therapies

Designations, candidates, and chemicals

FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.

Orphan designation (FDA · EMA)

No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.

Open Targets candidates

No drugs or clinical candidates returned for this Mondo ID on Open Targets.

CTD chemicals (MyDisease.info)

No CTD chemical associations returned for this Mondo ID.

Literature

Is anyone studying this?

2,025

2,025 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.

2,025 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).

1,353 in the last 10 years · low confidence

Phrase hits: 51 · MeSH hits: 0

Open Europe PMC search

Who's working on it?

326

Distinct author names in 51 sampled papers — named people below.

Who's working on it?

No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.

  1. 01
    Herman GE4 papers · 2015

    Center for Molecular and Human Genetics, The Research Institute at Nationwide Children's Hospital and Department of Pediatrics, The Ohio State University, Columbus, OH, USA, gail.herman@nationwidechildrens.org.

    Papers in Europe PMC
  2. 02
    Steiner RD4 papers · 2015

    Department of Pediatrics, Department of Molecular and Medical Genetics and Institute on Development and Disability, Doernbecher Children's Hospital, Oregon Health & Science University, Portland, OR, USA and Marshfield Clinic Research Foundation and the Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Marshfield and Madison, WI, USA.

    Papers in Europe PMC
  3. 03
    Boerkoel CF3 papers · 2012
    Papers in Europe PMC
  4. 04
    Kelley RI3 papers · 2016

    Department of Genetics & Genomics, Boston Children's Hospital, Boston, MA 02115, USA.

    Papers in Europe PMC
  5. 05
    Kratz LE3 papers · 2016

    Kennedy Krieger Institute, Johns Hopkins University, Baltimore, MD 21205, USA.

    Papers in Europe PMC
  6. 06
    Arbour L2 papers · 2010
    Papers in Europe PMC
  7. 07
    Chou A2 papers · 2010
    Papers in Europe PMC
  8. 08
    Cunningham D2 papers · 2015

    Center for Molecular and Human Genetics, The Research Institute at Nationwide Children's Hospital and Department of Pediatrics, The Ohio State University, Columbus, OH, USA.

    Papers in Europe PMC
  9. 09
    DeBarber AE2 papers · 2015

    Department of Physiology and Pharmacology.

    Papers in Europe PMC
  10. 10
    du Souich C2 papers · 2010

    Rare Disease Foundation, Vancouver, British Columbia, Canada. cdusouich@cw.bc.ca

    Papers in Europe PMC

Clinical research

Is a treatment being tested?

0

interventional trials for this specific condition

No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present).

Data as of 11 September 2026 · last trial check 11 September 2026

No matched interventional trials. This is true for 77.2% of diseases in the trials denominator (5501 of 7126). Here are the researchers publishing on it.

low confidence · 38.6th percentile (trials denominator)

Recruiting interventional trials

From the matched ClinicalTrials.gov set

No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.

See who's working on it — people publishing on this disease are often the practical next contact when no trial is listed.

Other registries (secondary)

Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.

raw 32 · after dedupe 32 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 32 · dropped 0 · fetched 2026-07-30

Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri

No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).

Uncertain / not reviewed (32)

Where to find support

Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.

Orphanet entry for CK syndrome — check Associations / patient organisations on that page.

India — NPRD

Last verified 2026-07-26

This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.

Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.

How we counted this

Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.

("CK syndrome" OR "X-linked intellectual disability-microcephaly-cortical malformation-thin habitus syndrome" OR "CK syndrome, X-linked recessive") OR ("NSDHL" OR "NSDHL syndrome" OR "NSDHL-related" OR "CK-related")

Run this search on Europe PMC

ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):

"CK syndrome" OR "X-linked intellectual disability-microcephaly-cortical malformation-thin habitus syndrome" OR "CK syndrome, X-linked recessive"

Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.

Query health: ok — strategies attempted: phrase; with hits: phrase

Run this search on ClinicalTrials.gov

Confidence reasoning

  • Preferred label is short or not clearly distinctive
  • No synonyms dropped by stoplist
  • No label/synonym collisions with other diseases in this corpus
  • Publication count (2025) is implausibly high for prevalence class "<1 / 1 000 000" — treat as possible over-matching, not a measure of research intensity

Ingested 2026-07-27T10:46:06.877Z